AVTX vs BLSM: stock comparison and AI forecast
Avalo Therapeutics, Inc. (AVTX) and Blossomhill Therapeutics, Inc. (BLSM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVTX Avalo Therapeutics, Inc.
- Market Cap
- $393M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BLSM Blossomhill Therapeutics, Inc.
- Market Cap
- $395M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AVTX and BLSM have similar market capitalizations ($393M and $395M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVTX | BLSM |
|---|---|---|
| Market Cap | $393M | $395M |
| EPS | $-3.50 | – |
Profitability & Margins
| Metric | AVTX | BLSM |
|---|---|---|
| ROE | -22.4% | – |
| ROA | -20.4% | – |
| ROIC | -19.4% | – |
| Operating Margin | -51614.7% | – |
| Net Margin | -56685.3% | – |
| EBT Margin | -56588.7% | – |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | AVTX | BLSM |
|---|---|---|
| Current Ratio | 19.31x | 5.42x |
| D/E Ratio | 0.09x | – |
| Financial Leverage | 1.09x | – |
| Interest Coverage | -7.7x | – |
| Working Capital | $387M | $82M |
Cash Flow
| Metric | AVTX | BLSM |
|---|---|---|
| Operating Cash Flow | -$68M | – |
Income Statement
| Metric | AVTX | BLSM |
|---|---|---|
| Operating Income | -$91M | – |
| Net Income | -$100M | – |
| R&D Expense | $59M | – |
Dividend & Shareholder Information
| Metric | AVTX | BLSM |
|---|---|---|
| Shares Outstanding | 54M | 32M |
| Net Income Growth | -292.0% | – |
| EPS Growth | -103.0% | – |
AVTX vs BLSM: stock comparison and AI forecast
Which is bigger, AVTX or BLSM?
AVTX and BLSM have similar market capitalizations ($393M and $395M).
Which one does Intratio's AI model rank higher, AVTX or BLSM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.